Company: ANTX
Filing Date: 2025-03-25
Form Type: 10-K
Source: 0000950170-25-044366
Chunk: 152

Company: AN2 Therapeutics, Inc.
Filing Date: 2025-03-25
Form: 10-K
Item: Item 1B
Chunk 152
---
 001-41331
     
    4.3
     
    March 29, 2023

    4.4
     
    Rights Agreement, dated as of August 15, 2024, between AN2 Therapeutics, Inc. and Equiniti Trust Company, LLC, which includes Form of Certificate of Designations of Series A Junior Participating Preferred Stock as Exhibit A, the Form of Rights Certificate as Exhibit B and the Summary of Rights to Purchase Preferred Stock as Exhibit C.
     
    8-K
     
    001-41331
     
    4.1
     
    August 19, 2024

    10.1#
     
    AN2 Therapeutics, Inc. 2017 Equity Incentive Plan, as amended.
     
    S-1
     
    333-263295
     
    10.1
     
    March 4, 2022

    10.2#
     
    Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise and Early Exercise Stock Purchase Agreement under the AN2 Therapeutics, Inc. 2017 Equity Incentive Plan.
     
    S-1
     
    333-263295
     
    10.2
     
    March 4, 2022

    10.3#
     
    AN2 Therapeutics, Inc. 2022 Equity Incentive Plan
     
    10-K
     
    001-41331
     
    10.3
     
    March 29, 2024

    10.4#
     
    Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the AN2 Therapeutics, Inc. 2022 Equity Incentive Plan.
     
    S-1
     
    333-263295
     
    10.4
     
    March 4, 2022

    10.5#
     
    Form of Restricted Stock Unit Grant Notice and Award Agreement under the AN2 Therapeutics, Inc. 2022 Equity Incentive Plan.
     
    10-K
     
    001-41331
     
    10.5
     
    March 29, 2024

    10.6#
     
    AN2 Therapeutics, Inc 1022